Investor Presentaiton

Manufacturing and R&D - Diverse Global Network OPERATIONS Mexico City, Mexico 15 Manufacturing Sites 13 U.S.FDA inspected units ■ 30 bn+ extended unit capacity Range of capabilities from API to formulations including tablets, capsules, liquids, injectables, dermatological, ophthalmics, inhalation New Jersey, USA Florida, USA 100 Global Commercial Presence 23 Countries where products are sold Countries with marketing offices 13 Countries with subsidiaries Minas Gerias, Brazil Oldenzaal, Netherlands Jammu Vadodara Ankleshwar Mandideep Indore Sikkim Nagpur Aurangabad Tarapur Pune Goa⚫ Vizag Manufacturing Research RESEARCH 7 R&D Sites ■ 440 US ANDAS; 291 approved ■50 pending US First to Files ■ Secured a total of 36 patents in FY21 LUPIN 11

View entire presentation